|
211
|
|
|
Mediator complex subunit 13L |
MRFACD, PROSIT240, THRAP2, TRAP240L |
Attention deficit hyperactivity disorder, Autism, Brachycephaly, Cerebral palsy, Clinodactyly, Congenital clubfoot, Congenital ocular coloboma, Corneal astigmatism, Cryptorchidism, Developmental delay, Developmental delay-facial dysmorphism syndrome, Dysarthria, Dysmorphic features, Frontal bossing, Mental retardation, Macroglossia, Macrostomia, Macrotia, Mental retardation and distinctive facial features with or without cardiac defects, Motor delay, Movement disorders, Multiple congenital anomalies, Neurodevelopmental disorders, Patent foramen ovale, Plagiocephaly, Ptosis, Strabismus, Transposition of great vessels, Vesicoureteral refluxView all (14 more) |
|
212
|
|
|
Malonyl-CoA decarboxylase |
MCD |
|
|
213
|
|
|
Microtubule actin crosslinking factor 1 |
ABP620, ACF7, KIAA0754, LIS9, Lnc-PMIF, MACF, OFC4 |
Breast cancer, Cerebellar hypoplasia, Colonic neoplasms, Colorectal cancer, Colorectal neoplasms, Developmental delay, Diabetes mellitus, Dysphagia, Hypoplasia of corpus callosum, Lissencephaly, Lissencephaly with complex brainstem malformation, Mental retardation, Pachygyria, Strabismus, Vascular diseases |
|
214
|
|
|
MAF bZIP transcription factor F |
U-MAF, hMafF |
|
|
215
|
|
|
Mitochondrial carrier 2 |
HSPC032, MIMP, SLC25A50 |
|
|
216
|
|
|
Mechanistic target of rapamycin kinase |
FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS |
Adenocarcinoma, Alternating exotropia, Alveolitis, Apnea, Aqueductal stenosis, Asthma, Autism, Benign neoplasm of bladder, Urinary bladder cancer, Bladder neoplasm, Bladder carcinoma, Breast cancer, Mammary neoplasms, Breast carcinoma, Capillary malformation, Carcinoma, Uterine cervix neoplasm, Cervical cancer, Chromophobe carcinoma, Colonic neoplasms, Colorectal neoplasms, Communicating hydrocephalus, Facial dysmorphism, Congenital exomphalos, Cortical dysplasia, Cryptorchidism, Delayed speech and language development, Developmental delay, Dolichocephaly, Dyscognitive seizures, Dysplastic corpus callosum, Endocrine system diseases, Epileptic encephalopathy, Exocrine pancreatic insufficiency, Expressive language delay, Focal cortical dysplasia, Focal seizures, Frontal bossing, Gastric cancer, Giant cell glioblastoma, Glioblastoma, Hemangioma, Hemimegalencephaly, Hydrocephalus, Hypertension, Hypoglycemia, Hypopigmentation disorder, Hypoplasia of corpus callosum, Hypospadias, Impaired cognition, Infantile spasms, Mental retardation, Isolated focal cortical dysplasia, Lactose intolerance, Left ventricular hypertrophy, Liver carcinoma, Lung carcinoma, Lymphatic metastasis, Malignant lymphoma, lymphocytic, intermediate differentiation, Lymphoma, lymphocytic, intermediate, Lymphoblastic leukemia, Macrocephaly, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, Macrostomia, Malformation of cortical development, Malignant neoplasm, Malignant uterine corpus neoplasm, Marfan syndrome, Megalencephaly, Melanoma, Mental depression, Mesothelioma, Metastatic melanoma, Myopia, Neuronal heterotopia, Optic disk drusen, Ovarian neoplasm, Ovarian cancer, Ovarian adenocarcinoma, Papillary renal carcinoma, Polymicrogyria, Pulmonary fibrosis, Renal carcinoma, Rhizomelia, Salaam seizures, Schizophrenia, Seizure, Sleep apnea, Smith-kingsmore syndrome, Specific learning disorder, Speech disorders, Strabismus, Thoracic hypoplasia, Thyroid carcinomaView all (79 more) |
|
217
|
|
|
MMS22 like, DNA repair protein |
C6orf167, dJ39B17.2 |
|
|
218
|
|
|
Methionine sulfoxide reductase B3 |
DFNB74 |
|
|
219
|
|
|
Methionyl aminopeptidase type 1D, mitochondrial |
MAP 1D, MAP1D, MetAP 1D, Metap1l |
|
|
220
|
|
|
Minichromosome maintenance 9 homologous recombination repair factor |
C6orf61, MCMDC1, ODG4, dJ329L24.1, dJ329L24.3 |
|
